Role of nafarelin in the management of endometriosis.
article
OA: closed
CC0
⤵ 11 in-corpus citations
AI-generated summary
Nafarelin relieved endometriosis symptoms, reduced laparoscopic scores, and improved fertility in women, with side effects limited to hypoestrogenism.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
A large, multicenter, double-blind clinical trial established that the gonadotropin releasing hormone analog nafarelin relieves clinical symptoms, decreases laparoscopic scores and improves fertility in women with endometriosis. Side effects were limited to those attributable to hypoestrogenism.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (11)
- Gonadotropin-releasing hormone analogues for endometriosis 2023
- Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis 2019
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 2010
- Ovulation suppression for endometriosis for women with subfertility 2007
- Management of the Pain Associated with Endometriosis: An Update of the Painful Problems 2006
- A Randomized, Parallel, Comparative Study of the Efficacy and Safety of Nafarelin Versus Danazol in the Treatment of Endometriosis in Taiwan 2005
- Ovulation suppression for endometriosis 2003
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 1999
- Endometriosis 1992
- Goserelin 1991
- Nafarelin 1990
Source provenance
- europepmc
- last seen: 2026-06-20T06:14:18.781669+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:09:10.744835+00:00
License: CC0
· commercial use OK